tiprankstipranks
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE

Ultragenyx Pharmaceutical (RARE) Similar Stocks

Compare
798 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Ultragenyx Pharmaceutical
$35.13
$3.13B
-25.38%
16 Buy
1 Hold
0 Sell
Strong Buy
Amicus
$8.00
$2.46B
-30.19%
7 Buy
3 Hold
0 Sell
Moderate Buy
BioMarin Pharmaceutical
$67.48
$12.87B
30.68
-22.34%
19 Buy
5 Hold
0 Sell
Strong Buy
Vertex Pharmaceuticals
$484.01
$124.29B
19.80%
16 Buy
10 Hold
1 Sell
Moderate Buy
Sarepta Therapeutics
$58.61
$5.69B
24.59
-53.82%
16 Buy
4 Hold
0 Sell
Strong Buy
Crispr Therapeutics AG
$32.66
$2.80B
-49.80%
12 Buy
7 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RARE
Ultragenyx Pharmaceutical
35.13
-15.11
-30.08%
FOLD
Amicus
8.00
-3.72
-31.74%
BMRN
BioMarin Pharmaceutical
67.48
-19.47
-22.39%
VRTX
Vertex Pharmaceuticals
484.01
77.34
19.02%
SRPT
Sarepta Therapeutics
58.61
-67.47
-53.51%
CRSP
Crispr Therapeutics AG
32.66
-30.24
-48.08%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis